Abstract
Central retinal artery occlusion (CRAO) is an ophthalmic emergency and represents the ocular equivalent of a cerebral stroke. Evidence shows that most CRAO patients suffer profound, acute vision loss, as well as an increased risk of subsequent cerebral stroke. There are no current, proven ocular treatments for CRAO. Management is targeted at evaluation and intervention of acute risk factors, preventing secondary ocular neovascular complications, and addressing underlying systemic comorbidities. This case report reviews the clinical features, etiologies, and management of CRAO. CE Notification: This article is available as a COPE accredited CE course. You may take this course for 1-hour credit. Read the article and take the qualifying test to earn your credit. Click here to Enroll (https://www.crojournal.com/clinical-findings-and-management-of-central-retinal-artery-occlusion) Please check COPE course expiry dates prior to enrollment. The COPE course test must be taken before the course expiry date.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
